Evolution of IL-23 Blockade in Inflammatory Bowel Disease

被引:2
|
作者
Danese, Silvio [1 ,2 ]
Peyrin-Biroulet, Laurent [3 ,4 ]
机构
[1] IRCCS San Raffaele, Gastroenterol & Endoscopy, Via Olgettina 60, I-20132 Milan, Italy
[2] Univ Vita Salute, Via Olgettina 60, I-20132 Milan, Italy
[3] Lorraine Univ, Dept Hepato Gastroenterol, Vandoeuvre Les Nancy, France
[4] Lorraine Univ, INSERM, U1256, Univ Hosp Nancy, Vandoeuvre Les Nancy, France
来源
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷 / SUPPL 2期
关键词
IBD;
D O I
10.1093/ecco-jcc/jjab188
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Synergy of IL-23 and Th17 Cytokines: New Light on Inflammatory Bowel Disease
    Shen, Wei
    Durum, Scott K.
    NEUROCHEMICAL RESEARCH, 2010, 35 (06) : 940 - 946
  • [22] Synergy of IL-23 and Th17 Cytokines: New Light on Inflammatory Bowel Disease
    Wei Shen
    Scott K. Durum
    Neurochemical Research, 2010, 35 : 940 - 946
  • [23] A Screen to Test the Role of IL-23 Receptor in Inflammatory Bowel Diseases
    Danesi, F.
    Philpott, M.
    Huebner, C.
    Bordoni, A.
    Ferguson, L. R.
    JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS, 2008, 1 (06) : 305 - 305
  • [24] Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency
    Mannon, Peter J.
    Fuss, Ivan J.
    Dill, Susie
    Friend, Julia
    Groden, Catherine
    Hornung, Ron
    Yang, Zhiqiong
    Yi, Chuli
    Quezado, Martha
    Brown, Margaret
    Strober, Warren
    GASTROENTEROLOGY, 2006, 131 (03) : 748 - 756
  • [25] IL-7/IL-23: A new therapeutic target in the inflammatory bowel diseases
    Malamut, G.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (03): : 354 - 356
  • [26] IL-23 and Th17 Disease in Inflammatory Arthritis
    Yago, Toru
    Nanke, Yuki
    Kawamoto, Manabu
    Kobashigawa, Tsuyoshi
    Yamanaka, Hisashi
    Kotake, Shigeru
    JOURNAL OF CLINICAL MEDICINE, 2017, 6 (09)
  • [27] IL-23 assists the transition from autoimmunity to inflammatory disease
    Villanueva, M. Teresa
    NATURE REVIEWS RHEUMATOLOGY, 2017, 13 (01) : 1 - 1
  • [28] IL-23 assists the transition from autoimmunity to inflammatory disease
    M. Teresa Villanueva
    Nature Reviews Rheumatology, 2017, 13 : 1 - 1
  • [29] IL-23 is highly expressed in inflammatory bowel disease and induces T cell proinflammatory cytokine secretion
    Liu, Zhanju
    Jiu, Jinxia
    Zhang, Huixia
    GASTROENTEROLOGY, 2008, 134 (04) : A645 - A645
  • [30] The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity
    Liu, Zhanju
    Yadav, Praveen K.
    Xu, Xiaorong
    Su, Jingling
    Chen, Chi
    Tang, Maochun
    Lin, Hui
    Yu, Jifeng
    Qian, Jiaming
    Yang, Ping-Chang
    Wang, Xingpeng
    JOURNAL OF LEUKOCYTE BIOLOGY, 2011, 89 (04) : 597 - 606